Marina E. Emborg

6.0k total citations · 1 hit paper
96 papers, 4.6k citations indexed

About

Marina E. Emborg is a scholar working on Cellular and Molecular Neuroscience, Neurology and Molecular Biology. According to data from OpenAlex, Marina E. Emborg has authored 96 papers receiving a total of 4.6k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Cellular and Molecular Neuroscience, 41 papers in Neurology and 35 papers in Molecular Biology. Recurrent topics in Marina E. Emborg's work include Parkinson's Disease Mechanisms and Treatments (32 papers), Neurological disorders and treatments (25 papers) and Nerve injury and regeneration (23 papers). Marina E. Emborg is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (32 papers), Neurological disorders and treatments (25 papers) and Nerve injury and regeneration (23 papers). Marina E. Emborg collaborates with scholars based in United States, Switzerland and France. Marina E. Emborg's co-authors include Shuang Yang, Ben Roitberg, Jeffrey H. Kordower, James E. Holden, Michael D. Taylor, Yaping Chu, Stéphane Palfi, Patrick Aebischer, Nicole Déglon and Philippe Hantraye and has published in prestigious journals such as Science, The Lancet and Nature Medicine.

In The Last Decade

Marina E. Emborg

93 papers receiving 4.5k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Neurodegeneration Prevented by Lentiviral Vector Delivery of GDNF in Primate Models of Parkinson's Disease

2000 1.0k citations Marina E. Emborg, Ben Roitberg et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Marina E. Emborg	2.3k	1.9k	1.5k	678	538	96	4.6k
Ronald L. Klein	1.7k 0.8×	2.2k 1.2×	655 0.4×	1.0k 1.5×	324 0.6×	93	4.3k
Matteo Caleo	2.4k 1.0×	1.8k 0.9×	1.4k 0.9×	359 0.5×	1.1k 2.0×	141	6.3k
Gudrun Ahnert‐Hilger	2.7k 1.2×	3.7k 2.0×	1.5k 1.0×	499 0.7×	393 0.7×	153	7.1k
X. William Yang	3.1k 1.4×	3.8k 2.0×	1.1k 0.7×	613 0.9×	428 0.8×	68	5.7k
Corinna Bürger	2.3k 1.0×	2.7k 1.4×	1.6k 1.1×	1.4k 2.0×	695 1.3×	66	6.3k
Herman van der Putten	4.4k 1.9×	3.1k 1.7×	1.5k 1.0×	730 1.1×	933 1.7×	92	7.4k
Victor L. Friedrich	1.6k 0.7×	2.8k 1.5×	1.1k 0.7×	520 0.8×	408 0.8×	109	6.6k
Hyder A. Jinnah	2.8k 1.3×	2.0k 1.1×	4.7k 3.1×	552 0.8×	462 0.9×	236	7.7k
Marina Mata	2.9k 1.3×	2.0k 1.1×	753 0.5×	921 1.4×	352 0.7×	125	5.9k
Ai Yamamoto	1.9k 0.8×	2.7k 1.5×	1.0k 0.7×	513 0.8×	422 0.8×	74	5.5k

Countries citing papers authored by Marina E. Emborg

Since Specialization

Citations

This map shows the geographic impact of Marina E. Emborg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marina E. Emborg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marina E. Emborg more than expected).

Fields of papers citing papers by Marina E. Emborg

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marina E. Emborg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marina E. Emborg. The network helps show where Marina E. Emborg may publish in the future.

Co-authorship network of co-authors of Marina E. Emborg

This figure shows the co-authorship network connecting the top 25 collaborators of Marina E. Emborg. A scholar is included among the top collaborators of Marina E. Emborg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marina E. Emborg. Marina E. Emborg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Emborg, Marina E., et al.. (2025). Advantages and challenges of using allogeneic vs. autologous sources for neuronal cell replacement in Parkinson’s disease: Insights from non-human primate studies. Brain Research Bulletin. 224. 111297–111297. 2 indexed citations

Eickhoff, Jens C., Ann M. Mitzey, Michele L. Schotzko, et al.. (2023). Quantification of early gait development: Expanding the application of Catwalk technology to an infant rhesus macaque model. Journal of Neuroscience Methods. 388. 109811–109811.

Ausderau, Karla, et al.. (2023). Evaluating depression- and anxiety-like behaviors in non-human primates. Frontiers in Behavioral Neuroscience. 16. 1006065–1006065. 7 indexed citations

Bondarenko, Viktoriya, et al.. (2021). Acute Exposure to the Food-Borne Pathogen Listeria monocytogenes Does Not Induce α-Synuclein Pathology in the Colonic ENS of Nonhuman Primates. Journal of Inflammation Research. Volume 14. 7265–7279. 2 indexed citations

Vermilyea, Scott, Jillian H. Kluss, Jenna Kropp Schmidt, et al.. (2020). In Vitro CRISPR/Cas9-Directed Gene Editing to Model LRRK2 G2019S Parkinson’s Disease in Common Marmosets. Scientific Reports. 10(1). 3447–3447. 41 indexed citations

Pickett, Kristen A., et al.. (2019). Spatiotemporal quantification of gait in common marmosets. Journal of Neuroscience Methods. 330. 108517–108517. 4 indexed citations

Vermilyea, Scott & Marina E. Emborg. (2018). In Vitro Modeling of Leucine-Rich Repeat Kinase 2 G2019S-Mediated Parkinson's Disease Pathology. Stem Cells and Development. 27(14). 960–967. 4 indexed citations

Sison, Samantha L., Scott Vermilyea, Marina E. Emborg, & Allison D. Ebert. (2018). Using Patient-Derived Induced Pluripotent Stem Cells to Identify Parkinson’s Disease-Relevant Phenotypes. Current Neurology and Neuroscience Reports. 18(12). 84–84. 36 indexed citations

Vermilyea, Scott, Michaël Meyer, Kim Smuga-Otto, et al.. (2017). Induced Pluripotent Stem Cell-Derived Dopaminergic Neurons from Adult Common Marmoset Fibroblasts. Stem Cells and Development. 26(17). 1225–1235. 25 indexed citations

10.

Vermilyea, Scott & Marina E. Emborg. (2015). α-Synuclein and nonhuman primate models of Parkinson's disease. Journal of Neuroscience Methods. 255. 38–51. 29 indexed citations

11.

Emborg, Marina E., Samuel A. Hurley, Valerie Joers, et al.. (2014). Titer and Product Affect the Distribution of Gene Expression after Intraputaminal Convection-Enhanced Delivery. Stereotactic and Functional Neurosurgery. 92(3). 182–194. 15 indexed citations

12.

Cibelli, José B., Marina E. Emborg, Darwin J. Prockop, et al.. (2013). Strategies for Improving Animal Models for Regenerative Medicine. Cell stem cell. 12(3). 271–274. 65 indexed citations

13.

Brady, Martin, Raghu Raghavan, Andrew L. Alexander, et al.. (2013). Pathways of Infusate Loss during Convection-Enhanced Delivery into the Putamen Nucleus. Stereotactic and Functional Neurosurgery. 91(2). 69–78. 39 indexed citations

14.

Simmons, Heather A., Valerie Joers, Christine R. Swanson, et al.. (2012). A Monoclonal Antibody-GDNF Fusion Protein Is Not Neuroprotective and Is Associated with Proliferative Pancreatic Lesions in Parkinsonian Monkeys. PLoS ONE. 7(6). e39036–e39036. 56 indexed citations

15.

Joers, Valerie, Timothy J. Kamp, Timothy A. Hacker, et al.. (2012). Nonuniform Cardiac Denervation Observed by 11C-meta-Hydroxyephedrine PET in 6-OHDA-Treated Monkeys. PLoS ONE. 7(4). e35371–e35371. 20 indexed citations

16.

Emborg, Marina E., Jeffrey M. Moirano, Viktoriya Bondarenko, et al.. (2009). Response of aged parkinsonian monkeys to in vivo gene transfer of GDNF. Neurobiology of Disease. 36(2). 303–311. 39 indexed citations

17.

Stephenson, Diane, et al.. (2005). The Effects of a Selective Dopamine D2 Receptor Agonist on Behavioral and Pathological Outcome in 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-Treated Squirrel Monkeys. Journal of Pharmacology and Experimental Therapeutics. 314(3). 1257–1266. 19 indexed citations

18.

Emborg, Marina E.. (2004). Evaluation of animal models of Parkinson's disease for neuroprotective strategies. Journal of Neuroscience Methods. 139(2). 121–143. 121 indexed citations

19.

Emborg, Marina E.. (2003). Rest tremor in rhesus monkeys with MPTP-induced parkinsonism. Frontiers in bioscience. 8(1). a148–154. 9 indexed citations

20.

Emborg, Marina E. & Jorge A. Colombo. (1994). Long-Term MPTP-Treated Monkeys Are Resistant to GM1 Systemic Therapy. Molecular and Chemical Neuropathology. 21(1). 75–82. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact